Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for assessing the response status for treatment of Inflammatory condition or disease affecting the digestive tract such as inflammatory bowel disease in human patients

Biomarkers for assessing the response status for treatment of Inflammatory condition or disease affecting the digestive tract such as inflammatory bowel disease in human patients

US Patent 12077820 · Granted Sep 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof2025
Antibodies directed against CD1272025
Uses of anti-SIRPg antibodies2025
Humanized anti-human-PD-1 antibody and methods of using them for cancer treatmen2025
Method effector cells using anti-CD127 antibodies for applications in cell thera2025
Anti-SIRPa antibodies and their therapeutic applications2025
Method of promoting a t-cell response or treating cancer by administering an ant2024
Antibodies and polypeptides directed against CD1272024
Use of anti-human SIRPa v1 antibodies and method for producing anti-SIRPa v1 ant2024
Methods and compositions for predicting chronic lung allograft dysfunction2023
Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibod2023
Methods for discriminating a tolerant subject2022